General Information of the Compound
| Compound ID |
CP0408811
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-deoxy-1-[6-(N'-benzoyl-hydrazino)-2-chloro-9H-purin-9-yl]-N-ethyl-beta-Dribofuranuronamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H20ClN7O5
|
||||||||||||||||||
| Molecular Weight |
461.866
|
||||||||||||||||||
| Canonical SMILES |
CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NNC(=O)c3ccccc3)nc(Cl)nc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H20ClN7O5/c1-2-21-17(31)13-11(28)12(29)18(32-13)27-8-22-10-14(23-19(20)24-15(10)27)25-26-16(30)9-6-4-3-5-7-9/h3-8,11-13,18,28-29H,2H2,1H3,(H,21,31)(H,26,30)(H,23,24,25)/t11-,12+,13-,18+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LHBZWRVXNSFSKQ-CVXDAYKESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT01279, Adenosine receptor A3